2008
DOI: 10.1097/01.ogx.0000325907.36552.f4
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Screening for Red Cell Antibodies, Other Than Anti-D, to Detect Hemolytic Disease of the Fetus and Newborn: A Population Study in The Netherlands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

11
155
1
10

Year Published

2010
2010
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(178 citation statements)
references
References 0 publications
11
155
1
10
Order By: Relevance
“…A wide variation from 0.9 to 7.1 % can be seen regarding alloimmunization rates in the D antigen-negative group [8,10,17]. The rate of alloimmunization in the D antigen-negative group is higher in present study.…”
Section: Discussionmentioning
confidence: 42%
See 1 more Smart Citation
“…A wide variation from 0.9 to 7.1 % can be seen regarding alloimmunization rates in the D antigen-negative group [8,10,17]. The rate of alloimmunization in the D antigen-negative group is higher in present study.…”
Section: Discussionmentioning
confidence: 42%
“…Alloimmunization rates in antenatal females ranged from 0.4 to 2.71 % [8][9][10][11][12][13][14][15][16].…”
Section: Discussionmentioning
confidence: 99%
“…The most common antibodies were anti-E, followed by anti-K and anti-C. Severe HDN resulting from immunization to antigens other than D and requiring intrauterine or postnatal transfusions developed in 21 of 567 (3.7 %) of the pregnancies that were at risk; the antibodies were anti-K in 11.6 %; anti-c in 8.5 %; anti-E in 1.1 %; and Rh antibodies other than anti-C, anti-D, or anti-E in 3.8 % [7]. Serum bilirubin direct 11.9 1.5…”
Section: Discussionmentioning
confidence: 99%
“…In particular, anti-c (anti-RH4) in the Rh system and anti-K (anti-KEL1) in the Kell system are the next most common causes of HDFN, while Rh antigens C (RH2) and E (RH5) only occasionally result in severe HDFN. 24,25 Analysis of fetal cff DNA obtained from maternal blood represents a noninvasive approach for determining whether the fetus is a carrier of the corresponding antigen. In this approach, the DNA of the fetus is detected in the venous blood of the mother.…”
Section: Discussionmentioning
confidence: 99%